全球基因組編輯市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球基因組工程和編輯市場預計將從2025年的113.4億美元成長至2034年的572.3億美元，2026年至2034年的複合年成長率（CAGR）為19.71%。該市場快速擴張得益於分子生物學的突破性進展，這些進展使得在醫療保健、農業和工業生物技術領域對遺傳物質進行精確修飾成為可能。 CRISPR-Cas系統、TALENs和鋅指核酸酶等基因組工程和編輯技術透過實現標靶基因插入、刪除或修飾，正在改變研發領域。人們對個人化醫療日益成長的興趣以及解決遺傳疾病的需求，顯著推動了市場需求。此外，製藥公司和研究機構加大投資，也加速了基因組工程和編輯平台的創新和應用。

基因編輯工具的進步以及遺傳性和慢性疾病日益普遍是推動成長要素。研究人員正在利用這些技術開發新型治療方法，包括基因療法和細胞療法。在農業領域，基因組工程和編輯技術透過培育產量更高、抗病性更強、營養價值更高的作物，促進了市場成長。此外，特定地區的監管支持和臨床試驗的擴展也推動了基因組工程和編輯應用的商業化。

該市場的未來前景仍然十分光明，持續的創新可望拓展其應用範圍並提升效率。更安全、更精準的編輯技術的發展將有助於解決倫理和安全方面的擔憂。在新興市場，隨著研究能力的提升，預計該技術的應用將會進一步擴大。隨著生物技術的進步，基因組編輯市場有望實現持續成長，並對整個產業產生變革性影響。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球基因組編輯市場：依產品與服務類型分類

• 市場分析、洞察與預測
• 試劑和耗材
• 軟體和系統
• 服務

第5章 全球基因組工程編輯市場：依技術分類

• 市場分析、洞察與預測
• 限制性內切酶
• 鋅指核酸酶（ZFN）
• 轉錄活化因子樣效應核酸酶（TALENs）
• 叢集的、規則間隔的短回文重複序列
• 反義詞
• 其他

第6章：全球基因組工程編輯市場：以交付方式分類

• 市場分析、洞察與預測
• Ex-vivo
• In-vivo

第7章 全球基因組工程編輯市場：依模式分類

• 市場分析、洞察與預測
• 寄售
• 內部

第8章 全球基因組工程編輯市場：依應用領域分類

• 市場分析、洞察與預測
• 動物基因工程
• 植物性因工程
• 藥物發現和藥物開發
• 診斷用途
• 細胞株工程
• 其他

第9章 全球基因組工程編輯市場：依最終用戶分類

• 市場分析、洞察與預測
• 生物技術和製藥公司
• 政府和學術研究機構的調查以及
• CRO（合約研究組織）的估算和預測。

第10章 全球基因組工程編輯市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 對中東和非洲市場的分析、洞察和預測。
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Integrated DNA Technologies Inc
  • New England Biolabs Inc
  • Sangamo Biosciences Inc
  • Genscript Biotech Corp
  • Agilent Technologies Inc
  • Creative Biogene
  • Intellia Therapeutics Inc
  • Lonza Group

The global genome engineering editing market size is expected to reach USD 57.23 Billion in 2034 from USD 11.34 Billion in 2025, growing at a CAGR of 19.71 during 2026-2034.This market is expanding rapidly as breakthroughs in molecular biology enable precise modification of genetic material across healthcare, agriculture, and industrial biotechnology. Genome engineering and editing technologies such as CRISPR-Cas systems, TALENs, and zinc finger nucleases are transforming research and therapeutic development by allowing targeted gene insertion, deletion, or correction. The rising focus on personalized medicine and the need to address genetic disorders are significantly driving demand. Additionally, increasing investments from pharmaceutical companies and research institutions are accelerating innovation and adoption of genome editing platforms.

Key growth drivers include advancements in gene-editing tools and the increasing prevalence of genetic and chronic diseases. Researchers are leveraging these technologies to develop novel therapies, including gene therapies and cell-based treatments. The agricultural sector is also contributing to market growth by using genome editing to develop crops with improved yield, resistance, and nutritional value. Furthermore, regulatory support in certain regions and the expansion of clinical trials are encouraging the commercialization of genome-editing applications.

Future prospects for this market remain highly promising, with continued innovation expected to expand its applications and improve efficiency. The development of safer and more precise editing techniques will address ethical and safety concerns. Emerging markets are likely to witness increased adoption due to growing research capabilities. As biotechnology continues to evolve, the genome engineering editing market is poised for sustained expansion and transformative impact across industries.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product and Service Type

• Reagents and Consumables
• Software and Systems
• Services

By Technology

• Restriction Enzymes
• Zinc-Finger Nucleases (ZFN)
• Transcription activator-like effector nucleases (TALEN)
• Clustered regularly interspaced short palindromic repeats (CRISPR)
• Antisense
• Others

By Delivery Method

• Ex-vivo
• In-vivo

By Mode

• Contract
• In-House

By Application

• Animal Genetic Engineering
• Plant Genetic Engineering
• Drug Discovery and Development
• Diagnostic Applications
• Cell Line Engineering
• Others

By End-User

• Biotech and Pharma Companies
• Government and Academic Research Institutes
• Contract Research Organizations (CROs)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc., Merck KGaA, Integrated DNA Technologies Inc., New England Biolabs Inc., Sangamo Biosciences Inc., Genscript Biotech Corp, Agilent Technologies Inc., Creative Biogene, Intellia Therapeutics Inc., Lonza Group

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOME ENGINEERING EDITING MARKET: BY PRODUCT AND SERVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Service Type
• 4.2. Reagents and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software and Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOME ENGINEERING EDITING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Restriction Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Zinc-Finger Nucleases (ZFN) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Transcription activator-like effector nucleases (TALEN) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Clustered regularly interspaced short palindromic repeats (CRISPR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Antisense Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOME ENGINEERING EDITING MARKET: BY DELIVERY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Delivery Method
• 6.2. Ex-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. In-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOME ENGINEERING EDITING MARKET: BY MODE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Mode
• 7.2. Contract Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. In-House Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOME ENGINEERING EDITING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Animal Genetic Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Plant Genetic Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Drug Discovery and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Diagnostic Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Cell Line Engineering Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENOME ENGINEERING EDITING MARKET: BY END-USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End-user
• 9.2. Biotech and Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Government and Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Contract Research Organizations (CROs) Estimates and Forecasts

By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL GENOME ENGINEERING EDITING MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product And Service Type
  • 10.2.2 By Technology
  • 10.2.3 By Delivery Method
  • 10.2.4 By Mode
  • 10.2.5 By Application
  • 10.2.6 By End-user
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product And Service Type
  • 10.3.2 By Technology
  • 10.3.3 By Delivery Method
  • 10.3.4 By Mode
  • 10.3.5 By Application
  • 10.3.6 By End-user
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product And Service Type
  • 10.4.2 By Technology
  • 10.4.3 By Delivery Method
  • 10.4.4 By Mode
  • 10.4.5 By Application
  • 10.4.6 By End-user
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product And Service Type
  • 10.5.2 By Technology
  • 10.5.3 By Delivery Method
  • 10.5.4 By Mode
  • 10.5.5 By Application
  • 10.5.6 By End-user
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast,
• 2022-2034 (USD MN)
• 10.6.1 By Product And Service Type
• 10.6.2 By Technology
• 10.6.3 By Delivery Method
• 10.6.4 By Mode
• 10.6.5 By Application
• 10.6.6 By End-user
• 10.6.7 Saudi Arabia
• 10.6.8 UAE
• 10.6.9 Israel
• 10.6.10 South Africa
• 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL GENOME ENGINEERING EDITING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Thermo Fisher Scientific Inc
  • 12.2.2 Merck KGaA
  • 12.2.3 Integrated DNA Technologies Inc
  • 12.2.4 New England Biolabs Inc
  • 12.2.5 Sangamo Biosciences Inc
  • 12.2.6 Genscript Biotech Corp
  • 12.2.7 Agilent Technologies Inc
  • 12.2.8 Creative Biogene
  • 12.2.9 Intellia Therapeutics Inc
  • 12.2.10 Lonza Group